Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and… read more.
Shionogi & Co., Ltd. announced the FDA has accepted for review a New Drug Application (NDA) from Shionogi Inc., its US subsidiary for ensitrelvir (Xocova, enensitrelvir fumaric acid,… read more.
Updated ESC Guidelines, published today at ESC Congress 2025, put a focus on a woman’s autonomy in making her own reproductive choices by promoting a transparent dialogue and… read more.
Two years ago, the Food and Drug Administration approved the sale of an over-the-counter birth control pill for the first time in the United States without a prescription…. read more.
Medtronic plc announced two FDA regulatory milestones that broaden the MiniMed 780G system portfolio: clearance of the SmartGuard algorithm as an interoperable automated glycemic controller (iAGC), enabling integration… read more.
A new article in Veterinary Pathology introduces a 9-point checklist designed to improve the reporting quality of studies that use artificial intelligence (AI)-based automated image analysis (AIA). As… read more.
Less than half of England has access to tirzepatide (Mounjaro) through their GP, despite the NHS roll-out of the weight-loss jab officially starting over two months ago, an… read more.
Novartis announced positive results from V-DIFFERENCE, a Phase IV study evaluating Leqvio (inclisiran) compared to placebo, both administered on top of individually optimized lipid-lowering therapy (LLT), in patients… read more.
A major study has investigated the relationship between walking and the risk of developing chronic lower back problems. The findings could save the healthcare system significant amounts of… read more.
Biogen announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation to zuranolone, an oral capsule licensed for the treatment of adult women with… read more.
Fibrosis of the lungs is often a silent disease until it’s too late. By the time patients are diagnosed, the scarring of their lung tissue is already advanced,… read more.
Medicines containing a type of PFAS or ‘forever chemical’ called fluorine are not leading to higher numbers of adverse drug reactions according to new data analysis. In a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
